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It was recently reported that activation of a subset of lateral hypothalamus (LH) GABAergic neurons induced both appetitive
(food-seeking) and consummatory (eating) behaviors in vGat-ires-cre mice, while inhibition or deletion of GABAergic neurons blunted
these behaviors. As food and caloric-dense liquid solutions were used, the data reported suggest that these LH GABAergic neurons may
modulate behaviors that function to maintain homeostatic caloric balance. Here we report that chemogenetic activation of this GABAergic
population in vGat-ires-cre mice increased consummatory behavior directed at any available stimulus, including those entailing calories
(food, sucrose, and ethanol), those that do not (saccharin and water), and those lacking biological relevance (wood). Chemogenetic
inhibition of these neurons attenuated consummatory behaviors. These data indicate that LH GABAergic neurons modulate
consummatory behaviors regardless of the caloric content or biological relevance of the consumed stimuli.
Neuropsychopharmacology (2016) 41, 1505–1512; doi:10.1038/npp.2015.304; published online 28 October 2015
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INTRODUCTION
Numerous points of evidence spanning many years have
implicated the lateral hypothalamus (LH) in modulating the
consumption of rewarding stimuli. The LH was originally
implicated in modulating feeding behavior by evidence
demonstrating that lesions of the LH reduced food
consumption while electrical stimulation of this region
promoted food intake (Anand and Brobeck, 1951; Delgado
and Anand, 1953). It was later shown that rodents will work
for electrical stimulation of LH neurons in proportion to
their energy balance (Hoebel and Teitelbaum, 1962; Hoebel
and Thompson, 1969), direct evidence that the LH is critical
in reward-seeking behaviors. Since these original observa-
tions, research has shown that the LH not only modulates
consummatory behaviors directed at natural rewards, such as
food and water, but is also a critical region in supporting the
consumption of drugs, including ethanol (Leibowitz, 2007;
Sprow et al, 2015). In fact, the LH is often considered to be a
key player woven into proposed reward neurocircuitry,
which also includes the mesolimbic dopaminergic system
and the extended amygdala (Koob, 2003; Koob and Le Moal,
2001).
The role of GABAergic receptor signaling within the LH
in modulating consummatory behaviors has been well
studied using pharmacological approaches (Kelly et al,
1977; Turenius et al, 2009a, b). Although pharmacological
approaches establish that GABA receptor signaling in
the LH modulates consummatory behaviors, conclusions
regarding the sources of GABA innervation, or the direct role
of local GABAergic neurons, are not possible using
traditional pharmacological approaches. Historically, direct
manipulation of specific cell populations was challenging,
but recently developed optogenetic and chemogenetic
approaches allow one to achieve this goal. In one recent
example, Jennings et al (2015) used a combination of
optogenetic, chemogenetic, and neuronal ablation proce-
dures to show that activation of LH GABAergic neurons
increased, and inhibition or ablation of GABAergic neurons
decreased, appetitive (food-seeking) and consummatory
(eating) behaviors.
The stimulus rewards used in the experiments conducted
by Jennings et al (2015) were either food or a caloric-dense
liquid solution. As such, one interpretation of their data is
that the LH GABAergic neurons under investigation regulate
behaviors directed at maintaining caloric balance. To directly
test this interpretation, we performed a series of studies
utilizing a chemogenetic approach. Designer receptors
exclusively activated by designer drugs (DREADDs) are
genetically modified muscarinic receptors that have lost their
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affinity for endogenous acetylcholine but can be activated by
an otherwise physiologically inert ligand, clozapine-N-oxide
(CNO). DREADDs have been developed that are coupled
through the Gq or Gi pathways to stimulate or inhibit
neuronal activity, respectively (Armbruster et al, 2007).
DREADDs are packaged in adeno-associated viral (AAV)
vectors and have been made to be cre-inducible. Thus when
combined with transgenic cre-line mice, one can target
DREADDs to specific neuronal populations. In the present
report, we injected DREADD viral vectors into the LH of
vGat-ires-cre mice (Vong et al, 2011) to selectively express
DREADDs on GABAergic neurons in the LH. Here we found
that activation of LH GABAergic neurons increased
consumption of any available stimulus, including those
entailing calories (food, sucrose, and ethanol), those lacking
calories (saccharin and water), and those lacking biological
relevance.
MATERIALS AND METHODS
Animals
All mice used in the present work were transgenic VGat-ires-
cre mice on a C57BL/6J genetic background obtained from
Dr Bradford Lowell (Vong et al, 2011). Four cohorts of mice
were used: Cohort 1 (14 male and 14 female mice), Cohort 2
(6 male and 8 female mice), Cohort 3 (11 male and 9 female
mice), and Cohort 4 (15 male mice). Mice were individually
housed in plastic cages located in a vivarium with an ambient
temperature of approximately 22 °C and reverse light/dark
cycle with lights off at 10:00 hours. Food (IsoPro RMH 3000,
Purina LabDiet, St Louis, MO) and water were available
ad libitum except during testing (see below). All procedures
used were in accordance with the National Institute of
Health guidelines and were approved by the University of
North Carolina Institutional Animal care and Use
Committee.
Surgery
Mice were bilaterally microinjected with 0.5 μl/side of
purified and concentrated AAV into the LH or the zona
incerta (ZI). For the LH surgeries, the following stereotaxic
coordinates were used: − 1.2 mm posterior to bregma,
± 1.2 mm lateral to midline, and − 5.1 mm ventral to the
skull surface. For the ZI surgeries, the stereotaxic coordinates
were: − 1.2 mm posterior to bregma, ± 1.2 mm lateral to
midline, and − 4.26 mm ventral to the skull surface. Details
on the DREADD virus can be found in the Supplementary
Section.
Mouse Cohort 1: Binge-Like Ethanol Drinking, Food,
and Water Consumption and Open-Field Locomotor
Activity
We used a 4-day ‘drinking-in-the-dark’ (DID) procedure
with the first cohort of mice, an animal model of binge-like
ethanol drinking which promotes high levels of ethanol that
are associated with blood ethanol concentrations (BECs) in
excess of 80 mg/dl in a 2–4-h testing period (Rhodes et al,
2005; Thiele and Navarro, 2014). Procedural details for the
DID procedure have recently been described elsewhere
(Thiele et al, 2014). Briefly, on days 1–3, beginning 3 h into
the dark cycle, water bottles were removed from all cages and
replaced with bottles containing a 20% (v/v) ethanol
solution. Mice had 2 h of access to ethanol after which
ethanol bottles were removed from cages and water bottles
were replaced.
Before stereotaxic surgery was performed, all animals went
through one 4-day DID cycle. Consumption data collected
during this initial test allowed us to distribute the animals
into three groups in such a way that baseline levels of ethanol
intake were similar between groups: mice were given bilateral
infusions into the LH (as described above) of the AAV8-
hSyn-DIO-hM3D(Gq)-mcherry) viral vector (n= 9), the
AAV8-hSyn-DIO-hM4D(Gi)-mcherry viral vector (n= 10),
or the AAV8-hSyn-DIO-mcherry viral vector (n= 9). For
surgery, mice were anesthetized with a cocktail of Ketamine
(117 mg/kg) and xylazine (7.92 mg/kg). After a 21-day
recovery period to allow time for virus transduction, DID
testing procedures were initiated. On days 1–3, mice were
habituated to intraperitoneal (i.p.) injections (5 ml/kg) by
giving injection of a 0.5% DMSO solution in isotonic saline
(the vehicle for CNO) just before ethanol access. The same
schedule was followed on day 4, except that ethanol access
was extended to 4 h and i.p. injections consisted of vehicle or
CNO (3 mg/kg in a 5 ml/kg injection volume). After the 4-h
consumption period in which consumption measures were
recorded hourly, tail blood samples were collected from the
tail vein of each animal. Blood samples were centrifuged, and
5 μl of plasma were analyzed for BECs using the Analox
Alcohol Analyzer (Analox Instruments USA, Lunenburg,
MA). After 3 days of rest, mice were run through another 4-
day DID procedure as described above except mice were
given an i.p. injection of the alternate solution (vehicle or
CNO) that they did not receive during the first DID test,
constituting a Latin square experimental design.
After binge-like ethanol consumption testing, these same
mice were used to assess the effects of LH GABAergic
neuronal manipulation on food and water consumption.
Mice were given an i.p. injection of vehicle or CNO in the
same dose and volume described above, and then food
measure were collected hourly over 4 h beginning 3 h into
the dark cycle. Mice were injected with vehicle or CNO in a
Latin square design, with approximately 1 week between
injections. Over the next 2 weeks, this same approach was
used to assess the effects of vehicle or CNO injection on
water consumption over a 2-h period beginning 3 h into the
dark cycle. Finally, over the final 2 weeks the effects of
vehicle or CNO injection on open-field activity were assessed
over a 2-h period beginning 3 h into the dark cycle. Mice
were injected with both vehicle and CNO in a Latin square
design, with each injection separated by 1 week. Mice were
then perfused using a standard procedure in our laboratory
(Navarro et al, 2008), and brains were section and slide
mounted to verify the placement of viral vectors.
Mouse Cohort 2: Binge-Like Saccharin and Sucrose
Consumption
Mice from cohort 2 were randomly distributed into two
groups and given bilateral infusions into the LH of either the
AAV8-hSyn-DIO-hM3D(Gq)-mcherry viral vector (n= 8)
or the AAV8-hSyn-DIO-hM4D(Gi)-mcherry viral vector
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(n= 6) using the same procedures described above. After a 3-
week recovery period, the effects of vehicle or CNO injection
on consumption of saccharin (0.15%) or sucrose (3%) were
assessed. The consumption procedures were identical to DID
procedures described above, except water was replaced by
saccharin or sucrose over a 2-h test beginning 3 h into the
dark cycle. A Latin square design was used such that each
animal received both vehicle and CNO on separate test days
separated by a week. Mice were first tested with the saccharin
solution for the first 2 weeks and then with the sucrose over
the next 2 weeks. Mice were then perfused to verify the
placement of viral vectors.
Mouse Cohort 3: Binge-Like Ethanol Drinking and Food
Intake Following GABAergic Neuronal Manipulations in
the ZI
DID and food intake procedures were identical to those
outlined for mouse cohort 1 above. After a presurgery run
through DID procedures, mice were distributed into three
groups based on ethanol consumption as above and treated
with one of the three viral vectors aimed at the ZI: AAV8-
hSyn-DIO-hM3D(Gq)-mcherry (n= 7), AAV8-hSyn-DIO-
hM4D(Gi)-mcherry (n= 7), or AAV8-hSyn-DIO-mcherry
(n= 6). Mice were then tested for the effects of vehicle or
CNO injections (presented in a Latin square design as above)
on binge-like ethanol drinking and then food intake. Mice
were then perfused to verify the placement of viral vectors.
Mouse Cohort 4: Wood Gnawing Behavior
Mice from cohort 4 were randomly distributed into two
groups and given bilateral infusions into the LH of either the
AAV8-hSyn-DIO-hM3D(Gq)-mcherry viral vector (n= 8) or
the AAV8-hSyn-DIO-mcherry viral vector (n= 7) using the
same procedures described above. Details on the wood
gnawing test can be found in Supplementary Section.
Statistical Analyses
All data were analyzed using repeated-measure analysis of
variance (ANOVA) with viral vector and sex (when
appropriate) as between-subjects variables and vehicle vs
CNO treatment as a within-subjects factor. For clarity, only
significant effects (main or interactions) are described in
detail below. When main effects or interaction effects were
significant, post-hoc comparisons, when necessary, were
performed using Bonferroni-corrected t-tests. All data are
presented as mean± SEM, and significance was accepted at
po0.05 (two-tailed).
RESULTS
Mouse Cohort 1: Binge-Like Ethanol Drinking, Food and
Water Consumption, and Open-Field Locomotor
Activity
Results from the binge-like ethanol consumption study (a–c)
and examples of AAV8-hSyn-DIO-mcherry (d), AAV8-
hSyn-DIO-hM3D(Gq)-mcherry (e), and AAV8-hSyn-DIO-
hM4D(Gi)-mcherry (f) virus expression in the LH are
presented in Figure 1. A repeated-measures (CNO vs
vehicle × virus condition × sex) ANOVA performed on the
2-h binge-like ethanol consumption data showed a signifi-
cant main effect of virus condition (F(2, 20)= 7.33, p= 0.004)
and a significant CNO vs vehicle × virus condition inter-
action effect (F(2, 20)= 35.93, po0.001). Interestingly,
post-hoc tests comparing CNO vs vehicle treatment showed
Figure 1 Results from the binge-like ethanol consumption study. Two- (a) and 4 h (b) binge-like ethanol (20%, v/v) consumption and blood ethanol
concentrations (BECs; c) and examples of AAV8-hSyn-DIO-mcherry (Control; d), AAV8-hSyn-DIO-hM3D(Gq)-mcherry (hM3D(Gq); e), and AAV8-hSyn-
DIO-hM4D(Gi)-mcherry (hM4D(Gi); f) virus expression in the LH. Relative to vehicle treatment, CNO significantly increased 2 h ethanol consumption, or
reduced 2 h ethanol consumption, in the hM3D(Gq)- or hM4D(Gi)-treated groups, respectively. All data are presented as mean± SEM. *Signifies po0.05
relative to vehicle within each DREADD virus condition as determined by Bonferroni corrected t-tests (two-tailed). LH, lateral hypothalamus;
ZI, zona incerta.
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that CNO treatment significantly increased 2 h ethanol
consumption in mice expressing the AAV8-hSyn-DIO-hM3D
(Gq)-mcherry virus in the LH, while CNO treatment
significantly blunted 2 h binge-like ethanol drinking in mice
expressing the AAV8-hSyn-DIO-hM4D(Gi)-mcherry virus in
the LH. There were no differences in binge-like ethanol drinking
between vehicle and CNO treatment in mice expressing the
control AAV8-hSyn-DIO-mcherry virus. A similar repeated-
measures ANOVA run on the 4-h binge-like ethanol consump-
tion data revealed a significant CNO vs vehicle× virus condition
interaction effect (F(2, 20)=4.58, p= 0.023). Despite the
significant interaction effect, post-hoc tests failed to reveal
significant differences between the CNO- and vehicle-treated
groups at any of the virus conditions. Finally, a repeated-
measures ANOVA run on the BEC data revealed a significant
CNO vs vehicle main effect (F(1, 20)=4.98, p=0.037), but
post-hoc tests failed to show a significant difference between the
CNO- and vehicle-treated groups.
Data showing 2 (a) and 4 h (b) food intake, 2 h water
consumption (c), and 2 h open-field locomotor activity
(d) are depicted in Figure 2. A repeated-measures (CNO
vs vehicle × virus condition × sex) ANOVA run on 2-h food
intake data revealed a significant main effect of virus condi-
tion (F( 2, 21)= 13.52, po0.001) and a significant CNO vs
vehicle × virus condition interaction effect (F(2, 21)= 20.15,
po0.001). Post-hoc tests indicated that relative to vehicle,
CNO significantly increased food intake, or reduced food
intake in mice expressing the AAV8-hSyn-DIO-hM3D(Gq)-
mcherry or AAV8-hSyn-DIO-hM4D(Gi)-mcherry virus in
the LH, respectively. On the other hand, there was no effect
of CNO vs vehicle treatment in mice expressing the AAV8-
hSyn-DIO-mcherry in the LH. A similar repeated-measures
ANOVA run on 4-h food intake data revealed a main
effect of virus condition (F(2, 21)= 6.36, p= 0.007) and a
significant CNO vs vehicle × virus condition interaction
effect (F(2, 21)= 4.57, p= 0.023). Post-hoc tests failed to
reveal significant differences between the CNO- and vehicle-
treated groups at any of the virus conditions. A repeated-
measures ANOVA run on 2-h water consumption data
revealed main effects of CON vs vehicle condition
(F(1, 21)= 79.15, po0.001) and virus condition (F(2, 21)=
71.43, po0.001), and a significant interaction effect between
CNO vs vehicle × virus condition variables (F(2, 21)= 96.78,
po0.001). Post-hoc tests run at each virus condition revealed
that relative to vehicle treatment CNO significantly increased
water drinking in mice expressing the AAV8-hSyn-DIO-
hM3D(Gq)-mcherry virus but did not alter water drinking
at any of the other virus conditions. Finally, a repeated-
measures ANOVA run on 2-h open-field locomotor activity
data revealed significant main effects of CNO vs vehicle
treatment condition (F(1, 21)= 9.21, p= 0.006) and virus
condition (F(2, 21)= 4.49, p= 0.024), but the interaction
between variables was not significant.
Mouse Cohort 2: Binge-Like Saccharin and Sucrose
Consumption
Two hour saccharin (a) and sucrose (b) consumption
are presented in Figure 3. A repeated-measures (CNO vs
vehicle × virus condition × sex) ANOVA performed on
saccharin intake data revealed a significant main effect of
virus condition (F(1, 10)= 6.44, p= 0.03) and a significant
CNO vs vehicle × virus condition interaction effect
(F(1, 10)= 10.05, p= 0.01). Post-hoc tests indicated that
relative to vehicle treatment, treatment with CNO signifi-
cantly increased saccharin intake or reduced saccharin intake
in mice expressing the AAV8-hSyn-DIO-hM3D(Gq)-mcherry
or AAV8-hSyn-DIO-hM4D(Gi)-mcherry virus in the LH,
Figure 2 Results reflecting 2 (a) and 4 h (b) food intake, 2 h water consumption (c), and 2 h open-field locomotor activity assessment (d). Relative to vehicle
treatment, CNO significantly increased 2 h food intake, or reduced 2 h ethanol consumption, in groups expressing hM3D(Gq) or hM4D(Gi) viruses in the LH,
respectively. Also relative to vehicle treatment CNO significantly increased water drinking in the hM3D(Gq) virus condition. All data are presented as
mean± SEM. *Signifies po0.05 relative to vehicle within each DREADD virus condition as determined by Bonferroni-corrected t-tests (two-tailed).
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respectively. A repeated-measures ANOVA run on sucrose
intake data revealed significant main effects of CNO vs
vehicle (F(1, 10)= 20.89, p= 0.001) and virus condition
(F(1, 10)= 31.49, po0.001) effects and a significant CNO vs
vehicle × virus condition interaction effect (F(1, 10)= 118.41,
po0.001). Post-hoc tests indicated that relative to vehicle
treatment, treatment with CNO significantly increased
sucrose intake or reduced sucrose intake in mice expressing
the AAV8-hSyn-DIO-hM3D(Gq)-mcherry or AAV8-hSyn-
DIO-hM4D(Gi)-mcherry virus in the LH, respectively.
Mouse Cohort 3: Binge-Like Ethanol Drinking and Food
Intake Following GABAergic Neuronal Manipulations in
the ZI
Two hour ethanol consumption (a) and food intake (b), and
examples of virus expression (c–e) in mice with viral vectors
aimed specifically at the ZI are presented in Figure 4.
Repeated-measures (CNO vs vehicle × virus condition × sex)
ANOVAs performed on ethanol consumption data revealed
a significant CNO vs vehicle × sex interaction effect
(F(1, 14)= 6.58, p= 0.022), which reflected greater consump-
tion of ethanol following CNO (1.75± 0.23 g/kg/2 h) relative
to vehicle (0.92± 0.25 g/kg/2 h) in female mice but slightly
lower consumption of ethanol following CNO (1.03± 0.21 g/
kg/2 h) relative to vehicle (1.17± 0.23 g/kg/2 h) in male mice.
Post-hoc test comparing ethanol consumption between
vehicle treatment and CNO treatment failed to show
significant effects for male mice, though CNO-treated female
mice did drink more ethanol than female vehicle-treated
mice. This outcome is difficult to explain as CNO is consi-
dered to be inert (Urban and Roth, 2015). A repeated-
measures ANOVA performed on 2-h food intake data
revealed a significant main effect of sex (F(1, 14)= 8.35,
Figure 3 Results reflecting 2 h 0.15% (w/v) saccharin (a), 3% (w/v) sucrose (b) consumption testing, and the 2-h wood gnawing test (c). Relative to vehicle
treatment, CNO significantly increased 2 h saccharin and sucrose intake, or reduced 2 h saccharin and sucrose intake, in groups expressing hM3D(Gq) or
hM4D(Gi) viruses in the LH, respectively. Further, CNO significantly increased wood gnawing (reflected as a reduction of wood weight) specifically in the
group expressing the hM3D(Gq) virus. All data are presented as mean± SEM. *Signifies po0.05 relative to vehicle within each DREADD virus condition as
determined by Bonferroni-corrected t-tests (two-tailed).
Figure 4 Results from the zona incerta (ZI) study. Two-hour 20% (v/v) ethanol consumption (a) and food intake (b), and examples of AAV8-hSyn-DIO-
mcherry (Control; c), AAV8-hSyn-DIO-hM3D(Gq)-mcherry (hM3D(Gq); d), and AAV8-hSyn-DIO-hM4D(Gi)-mcherry (hM4D(Gi); e) virus expression in the
ZI. When viruses were transduced specifically in the ZI, CNO treatment did not influence ethanol consumption or food intake in any of the virus conditions.
All data are presented as mean± SEM.
Lateral hypothalamus GABA and reward consumption
M Navarro et al
1509
Neuropsychopharmacology
p= 0.012), reflecting greater consumption of food by female
mice (25± 2.29 g/kg/2 h) relative to male mice (16.62±
2.09 g/kg/2 h). No other effects were statistically significant.
Mouse Cohort 4: Wood Gnawing Behavior
Results from the gnawing behavior experiment are presented
in Figure 3c. A repeated-measures (CNO vs vehicle × virus
condition) ANOVA revealed a significant main effect of both
drug and virus (F(1, 13)= 11.064, p= 0.005; F(1, 13)= 5.472,
p= 0.036, respectively) as well as a significant drug × virus
interaction (F(1, 13)= 8.707, p= 0.011). Post-hoc analyses
revealed the group of mice expressing the AAV8-hSyn-DIO-
hM3D(Gq)-mCherry virus and injected CNO were signifi-
cantly different from all other groups, reflecting a significant
reduction of wood weight over the 2-h test that was not
evident in the other groups.
DISCUSSION
The present report provides novel evidence that GABAergic
neurons of the LH modulate consummatory behaviors
directed at any available stimulus, including those entailing
calories (food, sucrose, and ethanol), those lacking calories
(saccharin, water), and those lacking biological relevance
(wood). The most critical observation was that activation of
GABAergic neurons in the LH induced robust consumma-
tory behaviors, while silencing of GABAergic neurons in the
LH robustly blunted consummatory behaviors. Alterations of
consummatory behaviors cannot easily be attributed to
secondary changes stemming from impairment of motor
function, as activation or inhibition of GABAergic neurons
in the LH did not significantly alter locomotor activity over a
2-h test, yet this same manipulation promoted robust
changes in the intake of rewarding substances. Unexpectedly,
there was a non-significant trend for reduced locomotor
activity following activation of GABAergic neurons in the
LH, but as this same manipulation increased consumption,
blunted activity is unlikely to be a confounding factor when
interpreting consummatory behaviors.
Previous pharmacological data have established that
GABA receptor signaling in the LH modulates consumma-
tory behaviors (Kelly et al, 1977; Turenius et al, 2009a, b).
Consistent with recent observations (Jennings et al, 2015),
the present data give new insight that was not possible with a
strictly pharmacological approach by providing direct
evidence for a role of local GABAergic neurons in the LH
in modulating consummatory behaviors. Importantly, our
work provides the first evidence that LH GABAergic neurons
modulate consumption of any available stimulus, regardless
of caloric content or biological relevance. Interestingly, LH
infusion of GABAA receptor agonists blunt, and antagonists
increase, food intake (Turenius et al, 2009a, b), essentially
opposite to the pattern of results presented here with regards
to activation and silencing of local GABAergic transmission.
These results suggest the possibility that GABAA receptors
are expressed on local GABAergic neurons in the LH or on
presynaptic neurons that provide excitatory input to
GABAergic neurons in the LH and, viewed this way, allow
pharmacological and chemogenetic data to be explained with
consistency.
It is of interest to consider the possible neurocircuitry by
which LH GABAergic neurons modulate consummatory
behaviors. MCH/GABAergic neurons in the LH project to
the VTA and NAc (Bittencourt et al, 1992; Dallvechia-
Adams et al, 2002; Saito et al, 2001; Sears et al, 2010)
and modulate consumption of natural and drug rewards
(Morganstern et al, 2010; Parker and Bloom, 2012). How-
ever, as we used the same vGat-ires-cre mice used by
Jennings et al (2015) and the same DREADD constructs,
MCH/GABAergic neurons are unlikely to be involved as cre
is not present in MCH neurons of the current vGat-ires-cre
mice (Jennings et al, 2015). Interestingly, a portion of NAc-
projecting GABAergic neurons from the LH likely modulate
NAc activity independent of neuropeptide signaling (Urstadt
and Stanley, 2015). If GABAergic signaling in these pathways
is necessary for the presently observed phenotypes, then one
would predict that local injection of GABAA receptor agonist
into the NAc would promote consumption (consistent with
activation of projecting GABAergic neurons from the LH),
while infusion of GABAA receptor antagonist into the NAc
would blunt reward consumption (consistent with silencing
of projecting GABAergic neurons from the LH). In fact, NAc
activation of GABAA receptor signaling increases, while
inhibition of GABAA receptor signaling decreases, reward
(food or ethanol) consumption (Klitenick and Wirtshafter,
1988; Melon and Boehm, 2011; Nowak et al, 1998; Urstadt
et al, 2013). Additional research is necessary to confirm the
potential role of LH to NAc GABAergic pathways in the
modulation of reward consumption. Interestingly, activation
of a VTA-projecting GABAergic pathway was recently
shown to increase food intake and aberrant gnawing
behaviors (Nieh et al, 2015), which is also a possible pathway
underlying the present observations.
It is important to consider the basic properties of the
DREADDs used in the present report. Though we did not
quantify the level of viral vector expression, there were
apparent differences in the expression levels between the
different virus groups (eg, Figure 1d–f). In particular, the
control virus appears to exhibit more intense florescent
activity relative to the DREADD viral vectors, though the
pattern or expression appears to be similar between viral
vectors. However, given that behavior mapped onto the
different viral vector groups as predicted (ie, increased
consumption following activation of the Gq DREADD,
reduced consumption following activation of the Gi
DREADD, and no changes in consumption in the control
virus group), any existing differences in viral vector
expression are unlikely to account for differences in behavior
between the different virus groups. In all studies that
included the use of the control AAV8-hSyn-DIO-mCherry,
there were no differences between groups given i.p. injection
of vehicle or the 3 mg/kg dose of CNO, verifying that CNO
injection alone was not responsible for the observed
phenotypes in animals expressing the activating AAV8-
hSyn-DIO-hM3D(Gq)-mCherry or silencing AAV8-hSyn-
DIO-hM4D(Gi)-mCherry viruses. Additionally, in no cases
were there significant differences between the different viral
vector groups under baseline (vehicle injection) conditions,
verifying that the DREADD viral vectors alone, when
compared with the control virus, did not promote behavioral
effects in the absence of CNO. Controlling the spread of
virus transduction is difficult, and in fact in our LH study we
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observed strong virus transduction in GABAergic neurons in
both the LH and ZI. Similar to the LH, much of the ZI is
comprised of a dense population of GABAergic neurons
(Watson et al, 2014). Although little is known about the
functional role of the ZI, the subthalamus region, which
includes the ZI, has been implicated in modulating
consumption of natural and drug rewards (Lardeux et al,
2009). Thus we could not initially rule out the possibility that
observed changes in reward consumption were modulated by
GABAergic transmission in the ZI rather than, or in addition
to, GABAergic transmission in the LH. To address this issue,
we adjusted our infusion coordinates to a more dorsal
position, thus allowing us to selectively target our viral
vectors to the ZI. In this experiment, i.p. injection of CNO
failed to alter food intake or ethanol consumption in a way
that depended on viral vector condition. This allowed us to
rule out a role for the ZI and to conclude with confidence
that GABAergic neurons, specifically in the LH, modulate
consummatory behaviors. Finally, functional DREADD
activity has been verified in numerous previous citations
(Ferguson et al, 2013; Hasegawa et al, 2014; Krashes et al,
2011; Sasaki et al, 2011), and we showed that our Vgat-ires-
cre mice expressing the AAV8-hSyn-DIO-hM3D(Gq)-
mCherry DREADD in the LH exhibited increased c-Fos
expression and electrophysiological activity following CNO
application (see Supplementary Materials, Supplementary
Figures S1 and S2).
In summary, here we provide the first direct evidence that
the LH GABAergic neurons under investigation modulate
the consumption of any available stimulus, include those
entailing calories (food, sucrose, and ethanol), those lacking
calories (saccharin and water), and those lacking biological
relevance (wood). These data indicate that, rather than
specifically regulating behaviors to maintain homeostatic
caloric balance, the LH GABAergic neurons under investiga-
tion modulate general consummatory behaviors, thus other
upstream or parallel circuits must modulate specific
motivationally driven behaviors (eg, hunger or thirst).
Additional research will be necessary to identify the specific
GABAergic neurocircuits that are involved.
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